Unknown NA INTERVENTIONAL 1-arm NCT01938339

Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer

Sponsor: Seoul National University Hospital

Conditions Prostate Cancer Recurrent Stage II Prostate Carcinoma Stage III Prostate Carcinoma

Interventions PET/MR

Updated 6 times since 2017 Last updated: Dec 3, 2013 Started: May 31, 2012 Primary completion: Apr 30, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Prostate Cancer Recurrent and Stage II Prostate Carcinoma and is currently ongoing. Seoul National University Hospital leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea